<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR46">
 <label>46.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Huleatt</surname>
    <given-names>JW</given-names>
   </name>
   <name>
    <surname>Nakaar</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Desai</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Hewitt</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Jacobs</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Tang</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>McDonald</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Song</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Evans</surname>
    <given-names>RK</given-names>
   </name>
   <name>
    <surname>Umlauf</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Tussey</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Powell</surname>
    <given-names>TJ</given-names>
   </name>
  </person-group>
  <article-title>Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin</article-title>
  <source>Vaccine</source>
  <year>2008</year>
  <volume>26</volume>
  <issue>2</issue>
  <fpage>201</fpage>
  <lpage>214</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2007.10.062</pub-id>
  <?supplied-pmid 18063235?>
  <pub-id pub-id-type="pmid">18063235</pub-id>
 </element-citation>
</ref>
